跳至主要内容
临床试验/CTRI/2023/03/050981
CTRI/2023/03/050981尚未招募不适用

TO STUDY THE ROLE OF SUPRACHOROIDAL INJECTION TRIAMCINOLONE IN NON-INFECTIOUS UVEITIS

GSVM MEDICAL COLLEGE1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2023年3月27日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
1) BCVA

研究概览

简要总结

This is Randomised prospective study , to assess the role of suprachoroidal injection of Triamcinolone in patients of non- infectious anterior, non-infectious intermediate and non-infectious posterior uveitis. Primary outcome will be BCVA  improvement in 3-15 days.

研究设计

研究类型
Interventional
分配方式
Adaptive randomization, such as minimization
盲法
Open Label

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Newly diagnosed patients of non-infectious anterior uveitis.
  • (2) Newly diagnosed patients of non-infectious intermediate uveitis.
  • (3) Newly diagnosed patients of non-infectious posterior uveitis.

排除标准

  • (1) Patients not willing to participate or ready for follow up.
  • (2) Patients with uncontrolled blood sugar.
  • (3) Patients with any ocular disease other than uveitis.
  • (4) Patients contraindicated for suprachoroidal injection eg.
  • thinned sclera, scleritis, staphylococcus.
  • (5) Patients of hypersensitivity for Triamcinolone.
  • (6) Patients diagnosed of any other posterior segment pathologies.

结局指标

主要结局

1) BCVA

时间窗: 3 days after injection

2) Slit lamp examination

时间窗: 3 days after injection

3) Intra ocular pressure

时间窗: 3 days after injection

次要结局

  • BCVA(Slit lamp examination)

研究者

发起方
GSVM MEDICAL COLLEGE
申办方类型
Government medical college

研究点 (1)

Loading locations...

相似试验